Tourbillon Capital Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Tourbillon Capital Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-70,955	Closed	-$9.9M	–	79
2018 Q2	$9.9M	Buy	+70,955	New	+$10.1M	0.38%	59
2018 Q1	–	Sell	-148,327	Closed	-$18.7M	–	77
2017 Q4	$19.6M	Buy	+148,327	New	+$17.4M	0.72%	32
2014 Q2	–	Sell	-56,000	Closed	-$3.33M	–	100
2014 Q1	$3.33M	Buy	+56,000	New	+$3.33M	0.16%	72

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tourbillon Capital Partners's GWPH Position: Q3 2018 in Review

Tourbillon Capital Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2018, closing a stake of 70,955 shares — an estimated $9.9M sold.

Tourbillon Capital Partners first reported a position in GWPH in Q1 2014 and held it in 3 quarters. The position peaked at $19.6M in Q4 2017. 272 funds tracked by Wall St. Rank hold GWPH as of Q3 2018.

Tourbillon Capital Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2018 after selling out during the quarter.
Tourbillon Capital Partners sold 70,955 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2018, an estimated $9.9M.
Tourbillon Capital Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 3 quarters.
Tourbillon Capital Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $19.6M in Q4 2017.
272 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2018.

Based on Tourbillon Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.